Press
See NewsPress releases
Euroafrica genomför omvänt förvärv av Deversify
Plattforms- och mediabolaget Euroafrica har ingått avtal om att göra ett omvänt förvärv av Deversify. Strukturaffären innebär en utspädning för Euroafricas aktieägare om 90 procent. Mosiki Svenska kommer att bli bolagets största aktieägare med ett aktieinnehav om cirka 12,5 procent efter genomförande av det omvända förvärvet. Inga andra aktieägare kommer inneha mer än 10 procent.
Read press articleEuroafrica Digital Ventures AB ingår avsiktsförklaring avseende omvänt förvärv av Deversify AB villkorat avyttring av dotterbolag
Euroafrica Digital Ventures AB ("Bolaget" eller "Euroafrica Digital Ventures") har ingått en avsiktsförklaring med majoritetsägarna i Deversify AB ("Deversify") genom vilken Euroafrica Digital Ventures ska förvärva samtliga aktier i Deversify ("Transaktionen"). Transaktionen är villkorad av att Bolaget avyttrar verksamheten i dotterbolaget Kupatana AB vartefter Kupatana AB avyttras samt att dotterbolagen Social Content AB och Afrieuro Digital Ventures Ltd. ("Dotterbolagen") avyttras och att extra bolagsstämma godkänner avyttringarna. Förhandlingar avseende avyttring av verksamheten i Kupatana AB och Dotterbolagen pågår och Bolaget avser att uppdatera marknaden så snart en överenskommelse är på plats. Kallelse till extra bolagsstämma för godkännande av avyttringarna kommer att offentliggöras genom separat pressmeddelande. Förutsatt att ett aktieöverlåtelseavtal ingås och fullföljs, att en tillfredsställande Due Diligence genomförs och att sedvanliga villkor uppfylls, avser Transaktionen att slutföras under det första halvåret 2024.
Read press articleDeversify’s breathalyser Acetack introduced on the Dutch market
KetoFitShop, the Netherlands-based company for metabolic health products such as low- carb, keto and gluten free solutions, is partnering with the Swedish health technology company Deversify to bring the ketone breathalyser Acetrack to further European markets.
Read press articleDeversify launches in Spain and in Portugal
Deversify takes the next step in Europe and enters the Spanish and Portuguese markets. The launch begins in Spain now in March, where Acetrack, Deversify's breathalyser that measures fat burning, will be launched. The expansion takes place in collaboration with EIT Health's Bridgehead Programme, which aims to facilitate market entry for European health entrepreneurs with the support of top local incubators and catalysts.
Read press articleDeversify and Diet Doctor start collaboration to improve metabolic health
Deversify and the health company Diet Doctor enter a commercial collaboration where existing products and services are combined and offered to both companies' customer bases. Deversify is world leading in the measurement of biomarkers in exhaled air as well as digital educational programs around metabolic health.
Read press articleTomorrow, the 12(th) of october, is the sugar free day
Tomorrow, the 12th of October, is the Sugar Free Day. Many people eat too much sugar, although most people know that many lifestyle diseases are linked to excessive sugar intake. Tomorrow, the 12th of October is the Sugar Free Day, a physical event is organised at Epicenter in Stockholm, as well as the opportunity to participate digitally.
Read press articleDeversify selected for EIT health´s Bridgehead programme 2022
Deversify AB is a Swedish health tech company offering solutions for improved individual health and wellbeing. The company has been handpicked as one of 29 start-ups and scale-ups to participate in the prestigious Bridgehead Programme. Bridgehead serves to support promising health companies in gaining crucial connections and experience through EIT Health’s vast and diverse network.
Read press articleDeversify AB strengthens board of directors and secures international VC investment
Deversify AB is a Swedish health tech company offering solutions for improved individual health and wellbeing. Following Deversify’s Annual General Meeting, a new Board of Directors has been appointed, the intention being for the Board to reflect the company's most recent developments and next priorities. Lena Söderström, professional Board Director, will be the new Chairman of the Board, consisting of Åsa Lang, CSO and Co-Founder at Deversify and Johan Willdeck, Head of M&A at Omegapoint.
Read press articleDeversify acquires Elitista, one of Sweden's leading educational companies in metabolic health
Elitista targets middle-aged women — one of Deversify's main customer groups for the ketone monitoring breathalyzer Acetrack.
Read press articleDeversify enters development agreement on new microsensors
Deversify AB announced today that they have signed a hardware research and development agreement with GattyInstruments AB – a start-up from the Royal Institute of Technology (KTH) with business focused on nano and MEMS technology for sensors.
Read press articleDeversify selects Partner Fondkommisionen as financial advisor
Deversify AB announced today that they have signed an agreement with Partner Fondkommission to act as Deversify’s financial advisor with a focus on Deversify’s planned fundraising 2021.
Read press article
Contact
We’re happy to talk with you if you questions, please contact us here.
If you have any questions or want to know more, please send us an email and we’ll help you as soon as possible.